Vallourec S.A (VLOWY) is a leading steel business based in the US. On 9 September Vallourec shares leapt 9.47% to a closing position of $1.85. However, over the last 12 months, Vallourec's share price has fallen by an alarming 58.72% from $4.36. Vallourec is listed on the PINK and employs 15,676 staff. All prices are listed in US Dollars.
Range of stock exchanges
Since the stock market crash that started in February 2020, Vallourec's share price has had significant negative movement.
Its last market close was $1.765, which is 90.86% down on its pre-crash value of $19.32 (accounting for the 26 May 2020 split) and 275.07% down on the lowest point reached during the March 2020 crash when the shares fell as low as $6.62 (accounting for the 26 May 2020 split).
If you had bought $1,000 worth of Vallourec shares at the start of February 2020, those shares would have been worth $474.39 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $85.09.
|52-week range||$1.66 - $9.93|
|50-day moving average||$1.7574|
|200-day moving average||$5.4055|
|Dividend yield||$0.899 (48.59%)|
|Earnings per share (TTM)||$-13.2714|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
|1 week (2021-09-10)||-2.70%|
|1 month (2021-08-17)||5.26%|
|3 months (2021-06-17)||-70.73%|
|6 months (2021-03-17)||-76.98%|
|1 year (2020-09-17)||-58.72%|
|2 years (2019-09-13)||-92.14%|
|3 years (2018-09-14)||-95.71%|
|5 years (2016-09-16)||-95.12%|
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Vallourec's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $346.5 million (£0.0 million).
The EBITDA is a measure of a Vallourec's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.1 billion|
|Operating margin TTM||4.61%|
|Gross profit TTM||$608.1 million|
|Return on assets TTM||1.59%|
|Return on equity TTM||-51.73%|
|Market capitalisation||$2.1 billion|
TTM: trailing 12 months
Dividend yield: 48.59% of stock value
Vallourec has recently paid out dividends equivalent to 48.59% of its share value annually.
Vallourec's most recent dividend payout was on 26 May 2020. The latest dividend was paid out to all shareholders who bought their shares by 6 July 2021 (the "ex-dividend date").
Vallourec's shares were split on a 1:40 basis on 26 May 2020. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vallourec shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Vallourec shares which in turn could have impacted Vallourec's share price.
Over the last 12 months, Vallourec's shares have ranged in value from as little as $1.66 up to $9.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Vallourec's is 3.8466. This would suggest that Vallourec's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Ever wondered how to buy shares in Rocket Lab USA? We explain how and compare a range of providers that can give you access to many brands, including Rocket Lab USA.
Ever wondered how to buy shares in Camber Energy? We explain how and compare a range of providers that can give you access to many brands, including Camber Energy.
Ever wondered how to buy shares in Aterian? We explain how and compare a range of providers that can give you access to many brands, including Aterian.
Ever wondered how to buy shares in eFFECTOR Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including eFFECTOR Therapeutics.
Ever wondered how to buy shares in Santhera Pharmaceuticals Holding AG? We explain how and compare a range of providers that can give you access to many brands, including Santhera Pharmaceuticals Holding AG.
Ever wondered how to buy shares in Basilea Pharmaceutica? We explain how and compare a range of providers that can give you access to many brands, including Basilea Pharmaceutica.
Ever wondered how to buy shares in AB Science S.A.? We explain how and compare a range of providers that can give you access to many brands, including AB Science.
Ever wondered how to buy shares in Acacia Pharma Group? We explain how and compare a range of providers that can give you access to many brands, including Acacia Pharma Group.
Ever wondered how to buy shares in Blue Water Acquisition? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Acquisition.
Learn more about Aditxt’s recent performance and where you can invest in Aditxt shares. We also run through some helpful rules of thumb for any investor.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.